LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Pheast Therapeutics…

Pheast Therapeutics Tech Stack

Media & News

Pheast Therapeutics's Email Address Formats

Pheast Therapeutics uses at least 1 format(s):
Pheast Therapeutics Email FormatsExamplePercentage
First.Last@pheast.comJohn.Doe@pheast.com
100%

Frequently Asked Questions

What is Pheast Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconPheast Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pheast Therapeutics have currently?

Minus sign iconPlus sign iconAs of December 2025, Pheast Therapeutics has approximately 39 employees across 1 continents, including North America. Key team members include Head Of Finance: T. M.Senior Director, Human Resources: I. N.It Manager: K. D.. Explore Pheast Therapeutics's employee directory with LeadIQ.

What industry does Pheast Therapeutics belong to?

Minus sign iconPlus sign iconPheast Therapeutics operates in the Biotechnology Research industry.

What is Pheast Therapeutics's email format?

Minus sign iconPlus sign iconPheast Therapeutics's email format typically follows the pattern of First.Last@pheast.com. Find more Pheast Therapeutics email formats with LeadIQ.

How much funding has Pheast Therapeutics raised to date?

Minus sign iconPlus sign icon As of December 2025, Pheast Therapeutics has raised $76M in funding. The last funding round occurred on Apr 26, 2022 for $76M.

When was Pheast Therapeutics founded?

Minus sign iconPlus sign iconPheast Therapeutics was founded in 2020.

Pheast Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $76M

    Pheast Therapeutics has raised a total of $76M of funding over 1 rounds. Their latest funding round was raised on Apr 26, 2022 in the amount of $76M.

  • $25M$50M

    Pheast Therapeutics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $76M

    Pheast Therapeutics has raised a total of $76M of funding over 1 rounds. Their latest funding round was raised on Apr 26, 2022 in the amount of $76M.

  • $25M$50M

    Pheast Therapeutics's revenue is estimated to be in the range of $25M$50M

Company Leadership

  • Stylized image of a person
    T. M.
    Head Of Finance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. N.
    Senior Director, Human Resources
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. D.
    It Manager
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.